Latest Strategy News

Merino & Co. has secured a significant new order from its Shanghai distribution partner, reinforcing its expanding footprint in China’s luxury apparel market and validating its strategic growth plans.

Spenda Limited has successfully raised $1.4 million through a private placement, attracting both new and existing sophisticated investors to support its product development and working capital needs.

Alvo Minerals reports continued success at its Touro Prospect in Central Brazil, with all recent drill holes intersecting significant copper and zinc sulphides along a 750m strike. The discovery reinforces the Palma Project’s potential as a major volcanic massive sulphide district.

Golden Horse Minerals has reported promising initial assay results from its maiden regional drilling program at Baby Queen and Lake View prospects, confirming shallow high-grade gold mineralisation and setting the stage for an expanded 2026 exploration campaign.

Liontown Limited has inked a binding two-year offtake agreement with Canmax Technologies for 150,000 wet metric tonnes of spodumene concentrate annually in 2027 and 2028, reinforcing its foothold in the lithium supply chain.

Hammer Metals has initiated a targeted 1,500m reverse circulation drilling campaign at its Yandal Gold Project, focusing on extending known gold mineralisation at Orelia North and exploring new anomalies at Bronzewing South.

Pure Resources has verified the presence of large to jumbo flake graphite at its Garnet Hills project in Western Australia, highlighting its potential for premium pricing and strategic US downstream applications.

Frontier Energy has raised $11.5 million through a share placement to advance the Stage One development of its Waroona Renewable Energy Project, underpinning key financing milestones.

Diablo Resources has validated exceptional high-grade silver and antimony mineralisation at its Star Range project in Utah, setting the stage for maiden drilling amid strong market demand for critical minerals.

InhaleRx Limited has secured $427,500 from an initial tranche of its $1 million capital raise, issuing 17.1 million shares to support its inhaled therapies targeting pain and mental health conditions.

Almonty Industries has announced a $15 million public offering of common shares in the US, aiming to accelerate development across its tungsten and molybdenum projects amid rising global demand.

Race Oncology has raised $3.22 million through a private placement to fund its HARNESS-1 Phase 1a/b trial targeting non-small cell lung cancer, with patient enrolment expected early next year.